Research Progress of Plant Active Compounds in Anti Osteoporosis

JIA Mingjie; LUO Jiayuan; JIANG Shilong; BAO Yihong

doi:10.13386/j.issn1002-0306.2021070228

Volume 43 Issue 16

Aug. 2022

Turn off MathJax

Article Contents

Abstract

References

Science and Technology of Food Industry > 2022 > 43(16): 400-412. > DOI: 10.13386/j.issn1002-0306.2021070228

JIA Mingjie, LUO Jiayuan, JIANG Shilong, et al. Research Progress of Plant Active Compounds in Anti Osteoporosis[J]. Science and Technology of Food Industry, 2022, 43(16): 400−412. (in Chinese with English abstract). doi: 10.13386/j.issn1002-0306.2021070228.

Citation:

PDF (2330 KB)

Research Progress of Plant Active Compounds in Anti Osteoporosis

1.
Northeast Forestry University, Harbin 150040, China
2.
Heilongjiang Feihe Dairy Company Limited, Beijing 100015, China

More Information

Received Date: July 19, 2021
Available Online: May 30, 2022

Graphical Abstract

Abstract

Abstract

Osteoporosis is a systemic bone disease characterized by decreased bone mass, osteopenia, and bone microstructure degradation. The cause is that the activity of osteoclasts is greater than that of osteoblasts, resulting in bone resorption greater than bone formation. The current method of treating osteoporosis is mainly through calcium supplementation or drug treatment, but it would be accompanied by disadvantages such as poor absorption, insignificant effect, and large side effects. Plant natural active ingredients have the characteristics of wide sources, abundant structure and less adverse reactions. They could be used as new methods to prevent and treat osteoporosis. This article summarizes the anti-osteoporosis effects of osteoporosis and plant active ingredients. Through the analysis of related signal pathways, transcription factors, protein expression and other aspects, the anti-osteoporosis mechanism of plant active ingredients and related clinical research are described. On this basis, the anti-osteoporosis products of medicinal and edible plants are introduced, aiming to provide theoretical support for the development of new drugs and functional foods.
- osteoporosis,
- plant natural ingredients,
- mechanism of action,
- homology of medicine and food

FullText(HTML)

References (111)

References

[1]	刘雅兰. 三种植物的化学成分及其抑制破骨细胞产生活性的研究[D]. 广州: 广东药科大学, 2020. LIU Y L. Study on chemical constituents of three plants and their inhibition effects on the formation of osteoclast cell[D] . Guangzhou: Guangdong Pharmaceutical University, 2020.
[2]	王曦悦, 张秀艳, 董馨, 等. 斑马鱼骨质疏松模型的研究应用[J]. 中国骨质疏松杂志,2021,27(6):901−905,909. [WANG X Y, ZHANG X Y, DONG X, et al. Research and application of zebrafish osteoporosis model[J]. Chinese Journal of Osteoporosis,2021,27(6):901−905,909. doi: 10.3969/j.issn.1006-7108.2021.06.023 WANG X Y, ZHANG X Y, DONG X, et al. Research and application of zebrafish osteoporosis model[J]. Chinese Journal of Osteoporosis, 2021, 27(6): 901-905, 909. doi: 10.3969/j.issn.1006-7108.2021.06.023
[3]	刘飞祥. 左归丸调控Orexin及其受体对骨代谢影响的分子机制研究[D]. 南京: 南京中医药大学, 2019. LIU F X. The mechanisms of Zuoguiwan on bone metabolism by regulating orexin-A and its receptors[D]. Nanjing: Nanjing University of Chinese Medicine, 2019.
[4]	刘云, 罗晓婷, 李崇, 等. 雌激素治疗绝经后骨质疏松症的研究进展[J]. 实用临床医学,2020,21(10):91−96. [LIU Y, LUO X T, LI C, et al. Research progress in treatment of postmenopausa osteoporosis with estrogenl[J]. Practical Clinical Medicine,2020,21(10):91−96. LIU Y, LUO X T, LI C, et al. Research progress in Treatment of Postmenopausa Osteoporosis with Estrogenl [J]. Practical Clinical Medicine, 2020, 21(10): 91-96.
[5]	DEMBITSKY V M, GLORIOZOVA T A, POROIKOV V V. Pharmacological profile of natural and synthetic compounds with rigid adamantane-based scaffolds as potential agents for the treatment of neurodegenerative diseases[J]. Biochemical and Biophysical Research Communications,2020,529(4):1225−1241. doi: 10.1016/j.bbrc.2020.06.123
[6]	陈文辉, 蒋云霞, 白蕊, 等. 中医药治疗老年性骨质疏松症研究进展[J]. 辽宁中医杂志,2021,48(5):210−213. [CHEN W H, JIANG Y X, BAI R, et al. Research progress on treatment of senile osteoporosis with traditional Chinese medicine[J]. Liaoning Journal of Traditional Chinese Medicine,2021,48(5):210−213. CHEN W H, JIANG Y X, BAI R, et al. Research progress on treatment of senile osteoporosis with traditional Chinese medicine[J]. Liaoning Journal of Traditional Chinese Medicine, 2021, 48(5): 210-213.
[7]	LI F, YANG X L, YANG X N, et al. Antiosteoporotic activity of echinacoside in ovariectomized rats[J]. Phytomedicine, 2013, 20(6): 549−557.
[8]	刘小沛, 王相东, 邢文文, 等. 右归丸联合西药治疗骨质疏松症的Meta分析[J]. 中国骨质疏松杂志,2021,27(6):781−787. [LIU X P, WANG X D, XING W W, et al. Meta-analysis of Yougui Pill combined with Western medicine in the treatment of osteoporosis[J]. Chinese Journal of Osteoporosis,2021,27(6):781−787. doi: 10.3969/j.issn.1006-7108.2021.06.001 LIU X P, WANG X D, XING W W, et al. Meta-analysis of Yougui Pill combined with Western medicine in the treatment of osteoporosis[J]. Chinese Journal of Osteoporosis, 2021, 27(6): 781-787. doi: 10.3969/j.issn.1006-7108.2021.06.001
[9]	伍文耀. 补肾壮骨汤联合西药治疗2型糖尿病骨质疏松症(肾阳虚)随机平行对照研究[J]. 实用中医内科杂志,2019,33(6):13−17. [WU W Y. Randomized parallel controlled study of Bushen Zhuanggu decoction combined with western medicine in treatment of type 2 diabetic osteoporosis (kidney yang deficiency)[J]. Journal of Practical Traditional Chinese Internal Medicine,2019,33(6):13−17. WU W Y. Randomized Parallel Controlled Study of Bushen Zhuanggu decoction combined with western medicine in treatment of Type 2 Diabetic osteoporosis (kidney yang deficiency)[J]. Journal of Practical Traditional Chinese Internal Medicine, 2019, 33(6): 13-17.
[10]	刘翼波, 李博. 胶原肽预防骨质疏松症及其作用机制研究进展[J]. 食品工业科技,2021,42(9):373−381. [LIU Y B, LI B. A review of collagen peptides in preventing osteoporosis and its mechanism[J]. Science and Technology of Food Industry,2021,42(9):373−381. LIU Y B, LI B. A review of collagen peptides in preventing osteoporosis and its mechanism[J]. Science and Technology of Food Industry, 2021, 42(9): 373-381.
[11]	唐亨方, 姚啸生, 戚晓楠. 补肾健脾类中药改善肠道菌群治疗骨质疏松症的机制分析[J]. 实用中医内科杂志,2021,35(3):1−4. [TANG H F, YAO X S, QI X N. Mechanism analysis on treatment of osteoporosis by improving intestinal flora with traditional Chinese medicine of tonifying kidney and strengthening spleen[J]. Journal of Practical Chinese Internal Medicine,2021,35(3):1−4. TANG H F, YAO X S, QI X N. Mechanism analysis on treatment of osteoporosis by improving intestinal flora with traditional Chinese medicine of tonifying kidney and strengthening spleen[J]. Journal of Practical Chinese Internal Medicine, 2021, 35(3): 1-4.
[12]	赵军, 李婧. 植物雌激素类单味中药抗绝经后骨质疏松实验研究进展[J]. 云南中医中药杂志,2019,40(10):80−82. [ZHAO J, LI J. Experimental research progress of phytoestrogens single-flavor traditional Chinese medicines against postmenopausal osteoporosis[J]. Yunnan Journal of Traditional Chinese Medicine and Materia Medica,2019,40(10):80−82. doi: 10.3969/j.issn.1007-2349.2019.10.028 ZHAO J, LI J. Experimental research progress of phytoestrogens single-flavor traditional Chinese medicines against postmenopausal osteoporosis[J]. Yunnan Journal of Traditional Chinese Medicine and Materia Medica, 2019, 40(10): 80-82. doi: 10.3969/j.issn.1007-2349.2019.10.028
[13]	AZAM Z, PANDEY V, GUPTA N, et al. Phytoconstituents as novel osteo-protective agents: Implications in bone health[J]. Frontiers in Bioscience-Landmark, 2020, 25: 1259-1296.
[14]	AN J, HAO D J, ZHANG Q, et al. Natural products for treatment of bone erosive diseases: The effects and mechanisms on inhibiting osteoclastogenesis and bone resorption[J]. International Immunopharmacology,2016,36:118−131. doi: 10.1016/j.intimp.2016.04.024
[15]	魏金星, 王诺鑫, 罗熠, 等. 植物来源天然小分子化合物防治骨质疏松症的研究进展[J]. 天津医药,2021,49(1):107−112. [WEI J X, WANG N X, LUO Y, et al. Research progress on prevention and treatment of osteoporosis with plant-derived natural small molecular compounds[J]. Tianjin Medical Journal,2021,49(1):107−112. doi: 10.11958/20202154 WEI J X, WANG N X, LUO Y, et al. Research progress on prevention and treatment of osteoporosis with plant-derived natural small molecular compounds[J]. Tianjin Medical Journal, 2021, 49(1): 107-112. doi: 10.11958/20202154
[16]	王新祥, 张允岭, 吴坚, 等. 药食同源的植物葛根对骨质疏松症的防治作用[A]. 第八届国际营养药膳高层论坛论文集, 2009: 141−149. WANG X X, ZHANG Y L, WU J, et al. The prevention and treatment effect of Pueraria lobata root with the same medicine and food on osteoporosis[A]. Proceedings of the 8th International Nutrition and Medicinal Diet Forum, 2009: 141−149.
[17]	LI W, LEE S H, JANG H D, et al. Antioxidant and anti-osteoporotic activities of aromatic compounds and sterols from Hericium erinaceum[J]. Molecules, 2017, 22(1): 108.
[18]	ZHAO X Y, MEI L J, PEI J J, et al. Sophoridine from sophora flower attenuates ovariectomy induced osteoporosis through the RANKL-ERK-NFAT pathway[J]. Journal of Agricultural and Food Chemistry,2017,65(44):9647−9654. doi: 10.1021/acs.jafc.7b03666
[19]	CHE C T, WONG M S, LAM C W K. Natural products from Chinese medicines with potential benefits to bone health[J]. Molecules, 2016, 21(3): 239.
[20]	阙文君. 骨转换生化标志物的研究进展[D]. 重庆: 重庆医科大学, 2014. QUE W J. The reseach progress of bone turnover markers[D]. Chongqing: Chongqing Medical University, 2014.
[21]	杨琳(Younglion). 温补肾阳中药治疗围绝经期综合征作用机理探讨[D]. 南京: 南京中医药大学, 2016. YANG L (Younglion). The discussion on mechanism of the kidney-warming herbs treating the perimenopausal syndrome[D]. Nanjing: Nanjing University of Chinese Medicine, 2016.
[22]	ABDALLAH H M, FARAG M A, ALGANDABY M M, et al. Osteoprotective activity and metabolite fingerprint via UPLC/MS and GC/MS of Lepidium sativumin ovariectomized rats[J]. Nutrients,2020,12(7):2075. doi: 10.3390/nu12072075
[23]	耿丹丹. 香豆素类化合物对大鼠成骨细胞生物活性的影响及ERK信号通路研究[D]. 石家庄: 河北医科大学, 2017. GENG D D. The effects of coumarin on biological activity of rat osteoblasts and the study of ERK pathway[D]. Shijiazhuang: Hebei Medical University, 2017.
[24]	朱林华, 戴春燕. 南药大果榕抗骨质疏松研究[J]. 广东化工,2020,47(10):61−62. [ZHU L H, DAI C Y. Progress on the chemical constituents and anti-osteoporosis activity of Ficus auriculata[J]. Guangdong Chemical Industry,2020,47(10):61−62. doi: 10.3969/j.issn.1007-1865.2020.10.027 ZHU L H, DAI C Y. Progress on the chemical constituents and anti-osteoporosis activity of Ficus auriculata[J]. Guangdong Chemical Industry, 2020, 47(10): 61-62. doi: 10.3969/j.issn.1007-1865.2020.10.027
[25]	王浩, 庄威, 薛晓鸥. 中药植物雌激素活性研究及其临床应用研究进展[J]. 吉林中医药,2018,38(3):364−368. [WANG H, ZHUANG W, XUE X O. Research progress and clinical application of phytoestrogen activity in traditional Chinese medicine[J]. Jilin Journal of Chinese Medicine,2018,38(3):364−368. WANG H, ZHUANG W, XUE X O. Research progress and clinical application of phytoestrogen activity in traditional Chinese Medicine[J]. Jilin Journal of Chinese Medicine, 2018, 38(3): 364-368.
[26]	蔡心银, 张紫佳. 植物雌激素药理作用及相关中药的研究进展[J]. 现代中药研究与实践,2020,34(2):75−78,86. [CAI X Y, ZHANG Z J. Pharmacological effects of phytoestrogens and research progress of related traditional Chinese medicine[J]. Research and Practice on Chinese Medicines,2020,34(2):75−78,86. CAI X Y, ZHANG Z J. Pharmacological effects of phytoestrogens and research progress of related traditional Chinese medicine[J]. Research and Practice on Chinese Medicines, 2020, 34(2): 75-78, 86.
[27]	陈梦, 赵丕文, 赵笛. 中药植物雌激素的药理作用研究进展[J]. 江苏中医药,2017,49(4):82−85. [CHEN M, ZHAO P W, ZHAO D. Research progress on the pharmacological effects of phytoestrogens in traditional Chinese medicine[J]. Jiangsu Journal of Traditional Chinese Medicine,2017,49(4):82−85. CHEN M, ZHAO P W, ZHAO D. Research progress on the pharmacological effects of phytoestrogens in traditional Chinese medicine[J]. Jiangsu Journal of Traditional Chinese Medicine, 2017, 49(4): 82-85.
[28]	郁桦, 常萍, 陈蓓旖, 等. 大豆异黄酮和牛初乳复合制剂对去卵巢大鼠骨质疏松症的改善及抗氧化作用[J]. 食品工业科技,2019,40(15):284−291. [YU H, CHANG P, CHEN B Y, et al. Melioration and antioxidation effect of complexes of soy isoflavones and bovine colostrum on osteoprosis of ovariectomized rats[J]. Science and Technology of Food Industry,2019,40(15):284−291. YU H, CHANG P, CHEN B Y, et al. Melioration and antioxidation effect of complexes of soy isoflavones and bovine colostrum on osteoprosis of ovariectomized rats[J]. Science and Technology of Food Industry, 2019, 40(15): 284-291.
[29]	邱俊杰, 王伟舟, 赵泽玉, 等. 白藜芦醇在绝经后骨质疏松症中抗氧化机制的研究进展[J]. 中国骨质疏松杂志,2020,26(9):1370−1374. [QIU J J, WANG W Z, ZHAO Z Y, et al. Advances in research on antioxidant mechanism of resveratrol in postmenopausal osteoporosis[J]. Chinese Journal of Osteoporosis,2020,26(9):1370−1374. doi: 10.3969/j.issn.1006-7108.2020.09.025 QIU J J, WANG W Z, ZHAO Z Y, et al. Advances in research on antioxidant mechanism of resveratrol in postmenopausal osteoporosis[J]. Chinese Journal of Osteoporosis, 2020, 26(9): 1370-1374. doi: 10.3969/j.issn.1006-7108.2020.09.025
[30]	石丹宁, 赵丕文. 中药治疗绝经后骨质疏松症及其作用机制的研究进展[J]. 环球中医药,2018,11(4):600−604. [SHI D N, ZHAO P W. Research developments treating postmenopausal on the use and mechanisms of action of traditional Chinese medicines in osteoporosis[J]. Global Traditional Chinese Medicine,2018,11(4):600−604. doi: 10.3969/j.issn.1674-1749.2018.04.035 SHI D N, ZHAO P W. Research developments treating postmenopausal on the use and mechanisms of action of traditional Chinese medicines in osteoporosis[J]. Global Traditional Chinese Medicine, 2018, 11(4): 600-604. doi: 10.3969/j.issn.1674-1749.2018.04.035
[31]	杨明琛, 袁梦欣, 陆维, 等. 黄精多糖体外消化特性及对Ⅱ型糖尿病小鼠肠道菌群的调节作用[J]. 现代食品科技,2021,37(8):14−21. [YANG M C, YUAN M X, LU W, et al. In vitro digestion properties of Polygonatum sibiricum polysaccharide and its regulatory action on the gut microbiota in T2DM mice[J]. Modern Food Science and Technology,2021,37(8):14−21. YANG M C, YUAN M X, LU W, et al. In vitro digestion properties of Polygonatum sibiricum polysaccharide and its regulatory action on the gut microbiota in T2DM mice[J]. Modern Food Science and Technology, 2021, 37(8): 14-21.
[32]	张梦柳. 补肾壮骨类中药多糖的抗骨质疏松作用及促进骨形成机制的初步探讨[D]. 广州: 广东药科大学, 2017. ZHANG M L. The anti-osteoporosis effects of polysaccharides of kidney reinforcing and bone strengthening traditional Chinese medicine and preliminary discussions on its mechanism of pro-osteogenesis[D]. Guangzhou: Guangdong Pharmaceutical University, 2017.
[33]	ZHENG H, HE B, WU T X, et al. Extraction, purification and anti-osteoporotic activity of a polysaccharide from Epimedium brevicornum Maxim. in vitro[J]. International Journal of Biological Macromolecules,2020:156.
[34]	XU F F, DING Y, GUO Y Y, et al. Anti-osteoporosis effect ofEpimedium via an estrogen-like mechanism based on a system-level approach[J]. Journal of Ethnopharmacology,2016:177.
[35]	徐浩军. 温肾强骨丸治疗老年性脾肾阳虚型骨质疏松症的临床疗效观察[D]. 兰州: 甘肃中医药大学, 2020. XU H J. Clinical observation on the therapeutic effect of Wenshenqianggu Pill on senlie osteoporosis of spleen lidney yang deficiency type [D]. Lanzhou: Gansu University of Chinese Medicine, 2020.
[36]	ZHANG D W, ZHANG S J, JIANG K M, et al. Bioassay-guided isolation and evaluation of anti-osteoporotic polysaccharides from Morinda officinalis[J]. Journal of Ethnopharmacology,2020,261:113113. doi: 10.1016/j.jep.2020.113113
[37]	刘汝银, 岳宗进, 包德明. 巴戟天多糖对骨质疏松模型大鼠5-HT、VEGF与体内矿物质含量影响研究[J]. 中国生化药物杂志,2015,35(4):59−62. [LIU R Y, YUE Z J, BAO D M. Study on the effect of Morinda officinalis in 5-HT, VEGF and mineral content of the rat model of osteoporosis[J]. Chinese Journal of Biochemical and Pharmaceuticals,2015,35(4):59−62. LIU R Y, YUE Z J, BAO D M. Study on the effect of Morinda officinalis in 5-HT, VEGF and mineral content of the rat model of osteoporosis[J]. Chinese Journal of Biochemical and Pharmaceuticals, 2015, 35(4): 59-62 .
[38]	刘亦恒, 吴多庆, 朱振标, 等. 巴戟天多糖对去卵巢大鼠骨质疏松症的防治作用[J]. 海南医学,2014,25(20):2973−2975. [LIU Y H, WU D Q, ZHU Z B, et al. Protective and therapeutic effects of Morindae officinails polysaccharides on osteoporosis of ovariectomized[J]. Hainan Medical Journal,2014,25(20):2973−2975. doi: 10.3969/j.issn.1003-6350.2014.20.1170 LIU Y H, WU D Q, ZHU Z B, et al. Protective and therapeutic effects of Morindae officinails polysaccharides on osteoporosis of ovariectomized[J]. Hainan Medical Journal, 2014, 25(20): 2973-2975. doi: 10.3969/j.issn.1003-6350.2014.20.1170
[39]	郎小琴, 高越, 周叶, 等. 牛膝多糖对老年骨质疏松大鼠模型骨代谢及生物力学特征的影响[J]. 中华全科医学,2019,17(4):547−550,589. [LANG X Q, GAO Y, ZHOU Y, et al. Influence of achyranthan on bone metabolism and biomechanical characteristics of elderly rats model of osteoporosis[J]. Chinese Journal of General Practice,2019,17(4):547−550,589. LANG X Q, GAO Y, ZHOU Y, et al. Influence of achyranthan on bone metabolism and biomechanical characteristics of elderly rats model of osteoporosis[J]. Chinese Journal of General Practice, 2019, 17(4): 547-550, 589 .
[40]	LIN J, LI T Y, YU Q, et al. Structural characterization and in vitro osteogenic activity of ABPB-4, a heteropolysaccharide from the rhizome of Achyranthes bidentata[J]. Carbohydrate Polymers,2021:259.
[41]	WANG F J, TU P F, ZENG K W, et al. Total glycosides and polysaccharides of Cistanche deserticola prevent osteoporosis by activating Wnt/beta-catenin signaling pathway in SAMP6 mice[J]. Journal of Ethnopharmacology,2021:271.
[42]	毕萃萃, 刘银路, 魏芬芬, 等. 肉苁蓉的主要化学成分及生物活性研究进展[J]. 药物评价研究,2019,42(9):1896−1900. [BI C C, LIU Y L, WEI F F, et al. Research progress on main chemical constituents and biological activities of Cistanche deserticola[J]. Drug Evaluation Research,2019,42(9):1896−1900. BI C C, LIU Y L, WEI F F, et al. Research progress on main chemical constituents and biological activities of Cistanche deserticola[J]. Drug Evaluation Research, 2019, 42(9): 1896-1900.
[43]	徐俊. 防风多糖治疗骨质疏松大鼠的效果及对血清IL-6、TNF-α、TGFβ1、NO、NOS水平的影响[J]. 中华中医药学刊,2018,36(3):678−680. [XU J. Effect of polysaccharide on osteoporosis in rats and its effects on serum levels of IL-6, TNF-α, TGFβ1, NO and NOS[J]. Chinese Archives of Traditional Chinese Medicine,2018,36(3):678−680. XU J. Effect of polysaccharide on osteoporosis in rats and its effects on serum levels of IL-6, TN-alpha, TGF beta 1, NO and NOS[J]. Chinese Archives of Traditional Chinese Medicine, 2018, 36(3): 678 -680.
[44]	李高峰, 郑卫东, 张季铠, 等. 防风多糖对骨质疏松大鼠的作用及机制研究[J]. 中成药,2014,36(11):2399−2401. [LI G F, ZHENG W D, ZHANG J K, et al. Study on the effect and mechanism of Fangfeng polysaccharide on osteoporotic rats[J]. Chinese Traditional Patent Medicine,2014,36(11):2399−2401. doi: 10.3969/j.issn.1001-1528.2014.11.041 LI G F, ZHENG W D, ZHANG J K, et al. Study on the effect and mechanism of Fangfeng polysaccharide on osteoporotic rats[J]. Chinese Traditional Patent Medicine, 2014, 36(11): 2399-2401. doi: 10.3969/j.issn.1001-1528.2014.11.041
[45]	张小钰, 陈慧, 马敬祖, 等. 黄芪多糖治疗对去卵巢诱导骨质疏松大鼠骨密度、骨量和骨代谢的影响[J]. 中国骨质疏松杂志,2021,27(1):21−25. [ZHANG X Y, CHEN H, MA J Z, et al. Effect of astragalus polysaccharide treatment on bone mineral density, bone mass, and bone metabolism in ovariectomized osteoporotic rats[J]. Chinese Journal of Osteoporosis,2021,27(1):21−25. doi: 10.3969/j.issn.1006-7108.2021.01.005 ZHANG X Y, CHEN H, MA J Z, et al. Effect of astragalus polysaccharide treatment on bone mineral density, bone mass, and bone metabolism in ovariectomized osteoporotic rats[J]. Chinese Journal of Osteoporosis, 2021, 27(1): 21- 25. doi: 10.3969/j.issn.1006-7108.2021.01.005
[46]	薛志远. 红芪和黄芪抗骨质疏松、抗氧化及抗肝损伤作用比较研究[D]. 兰州: 兰州大学, 2018. XUE Z Y. Comparative study of radix hedysari radix astragali on anti-osteoporosis and antioxidant and hepatoprotective activities[D]. Lanzhou: Lanzhou University, 2018.
[47]	LIU J S, LIU J, LIU L, et al. The gut microbiota alteration and the key bacteria in Astragalus polysaccharides (APS)-improved osteoporosis[J]. Food Research International,2020,138(PB):109811.
[48]	林汉明. 补益肝肾活血通络法治疗绝经后骨质疏松症的临床疗效观察[D]. 福州: 福建中医药大学, 2020. LIN H M. Clinical observation on nourishing liver and kidney, and removing blood stasis and freeing vessel metod to treat the postmenopausal osteoporosis[D]. Fuzhou: Fujian University of Traditional Chinese Medicine, 2020.
[49]	DU L, NONG M N, ZHAO J M, et al. Polygonatum sibiricum polysaccharide inhibits osteoporosis by promoting osteoblast formation and blocking osteoclastogenesis through Wnt/β-catenin signalling pathway[J]. Scientific Reports, 2016, 6(1): 32261.
[50]	CUI X W, WANG S Y, CAO H, et al. A review: The bioactivities and pharmacological applications of Polygonatum sibiricum polysaccharides[J]. Molecules, 2018, 23(5): 1170.
[51]	HAN S Y, HU M H, QI G Y, et al. Polysaccharides from Polygonatum inhibit the proliferation of prostate cancer-associated fibroblasts[J]. Asian Pacific Journal of Cancer Prevention: APJCP, 2016, 17(8): 3829-3833.
[52]	叶松庆, 李永全. 黄精多糖对骨质疏松性骨折大鼠骨修复及骨代谢因子的影响[J]. 中国临床药理学杂志,2019,35(18):2128−2131. [YE S Q, LI Y Q. Effects of Polygonatum polysaccharides on bone repair and bone metabolism factors in rats with osteoporotic fracture[J]. The Chinese Journal of Clinical Pharmacol,2019,35(18):2128−2131. YE S Q, LI Y Q. Effects of Polygonatum polysaccharides on bone repair and bone metabolism factors in rats with osteoporotic fracture[J]. The Chinese Journal of Clinical Pharmacol, 2019, 35(18): 2128-2131.
[53]	张磊, 曾高峰, 宗少晖, 等. 黄精多糖防治绝经后骨质疏松症的分子机制[J]. 中国组织工程研究,2018,22(4):493−498. [ZHANG L, ZENG G F, ZONG S H, et al. Effect of polysaccharide on bone repair and bone metabolic factor in rats with osteoporotic fracture[J]. Chinese Journal of Tissue Engineering Research,2018,22(4):493−498. doi: 10.3969/j.issn.2095-4344.0079 ZHANG L, ZENG G F, ZONG S H, et al. Effect of polysaccharide on bone repair and bone metabolic factor in rats with osteoporotic fracture[J]. Chinese Journal of Tissue Engineering Research, 2018, 22(4): 493-498. doi: 10.3969/j.issn.2095-4344.0079
[54]	邓佩佩, 谢新宇, 王晶珂, 等. 枸杞多糖的研究现状[J]. 化学与生物工程,2018,35(4):7−11,15. [DENG P P, XIE X Y, WANG J K, et al. Research status of Lycium barbarum polysaccharide[J]. Chemical and Bioengineering,2018,35(4):7−11,15. doi: 10.3969/j.issn.1672-5425.2018.04.002 DENG P P, XIE X Y, WANG J K, et al. Research status of Lycium barbarum polysaccharide[J]. Chemical and Bioengineering, 2018, 35(4): 7-11, 15. doi: 10.3969/j.issn.1672-5425.2018.04.002
[55]	钟诚, 孙国栋, 范全, 等. 海藻酸钙/枸杞多糖凝胶微球对小鼠骨质疏松的作用研究[J]. 中国骨质疏松杂志,2021,27(3):319−323,336. [ZHONG C, SUN G D, FAN Q, et al. Effect of calcium alginate/lycium osteoporotic mice barbarum polysaccharides gel microspheres on osteoporotic mice[J]. Chinese Journal of Osteoporosis,2021,27(3):319−323,336. doi: 10.3969/j.issn.1006-7108.2021.03.002 ZHONG C, SUN G D, FAN Q, et al. Effect of calcium alginate/lycium osteoporotic mice barbarum polysaccharides gel microspheres on osteoporotic mice[J]. Chinese Journal of Osteoporosis, 2021, 27(3): 319-323, 336. doi: 10.3969/j.issn.1006-7108.2021.03.002
[56]	JING L, HU B W, SONG Q H. Lycium barbarum polysaccharide (LBP) inhibits palmitic acid (PA)-induced MC3T3-E1 cell apoptosis by regulating miR-200b-3p/Chrdl1/PPAR gamma[J]. Food & Nutrition Research,2020,64:4208.
[57]	张志宏, 邢娜, 彭东辉, 等. 中药抗骨质疏松作用及机制的研究进展[J]. 中国药房,2021,32(3):374−379. [ZHANG Z H, XING N, PENG D H, et al. Research progress of anti-osteoporosis effect and mechanism of Chinese medicine[J]. China Pharmacy,2021,32(3):374−379. doi: 10.6039/j.issn.1001-0408.2021.03.21 ZHANG Z H, XING N, PENG Dong H, et al. Research progress of anti-osteoporosis effect and mechanism of Chinese medicine[J]. China Pharmacy, 2021, 32(3): 374-379. doi: 10.6039/j.issn.1001-0408.2021.03.21
[58]	XIAO Y H, WEI R. Rutin suppresses FNDC1 expression in bone marrow mesenchymal stem cells to inhibit postmenopausal osteoporosis[J]. American Journal of Translational Research,2019,11(10):6680−6690.
[59]	邢菊玲, 党院霞, 刘芬, 等. 桑白皮总黄酮联合知母总皂苷改善高脂血症伴骨质疏松症大鼠的作用机制[J]. 中国实验方剂学杂志,2021,27(2):37−43. [XING J L, DANG Y X, LIU F, et al. Effect mechanism of total flavonoid of mori cortex combined with total saponins of Anemarrhenar rhizoma on hyperlipidemia rats with osteoporosis[J]. Chinese Journal of Experimental Traditional Medical Formulas,2021,27(2):37−43. XING J L, DANG Y X, LIU F, et al. Effect mechanism of total flavonoid of mori cortex combined with total saponins of Anemarrhenar rhizoma on hyperlipidemia rats with osteoporosis[J]. Chinese Journal of Experimental Traditional Medical Formulas, 2021, 27(2): 37-43.
[60]	王慧娟. 桑白皮黄酮类化合物抗骨质疏松活性及作用机制的研究[D]. 贵阳: 贵州大学, 2019. WANG H J. Study on the anti-osteoporosis activity and mechanism of flavonoids from cortex mori[D]. Guiyang: Guizhou University, 2019.
[61]	LIU C Y, ZHU R Y , LIU H X, et al. Aqueous extract of mori folium exerts bone protective effect through regulation of calcium and redox homeostasis via PTH/VDR/CaBP and AGEs/RAGE/Nox4/NF-kappa B signaling in diabetic rats[J]. Frontiers in Pharmacology, 2018, 9: 1239.
[62]	WANG H J, FENG T T, GUO D G, et al. Sanggenon C stimulates osteoblastic proliferation and differentiation, inhibits osteoclastic resorption, and ameliorates prednisone-induced osteoporosis in zebrafish model[J]. Molecules, 2018, 23(9): 2343.
[63]	李紫微, 曹庸, 苗建银. 大豆异黄酮及其苷元的研究进展[J]. 食品工业科技,2019,40(20):348−355. [LI Z W, CAO Y, MIAO J Y. Research progress of soy isoflavones and aglycones[J]. Science and Technology of Food Industry,2019,40(20):348−355. LI Z W, CAO Y, MIAO J Y. Research Progress of Soy Isoflavones and Aglycones[J]. Science and Technology of Food Industry, 2019, 40(20): 348-355.
[64]	王宁涛, 黄争美, 张志愿, 等. 大豆异黄酮抗骨质疏松作用的研究进展[J]. 中华实验外科杂志,2018,35(1):176−178. [WANG N T, HUANG Z M, ZHANG Z Y, et al. Research progress of soybean isoflavones on anti-osteoporosis[J]. Chinese Journal of Experimental Surgery,2018,35(1):176−178. doi: 10.3760/cma.j.issn.1001-9030.2018.01.057 WANG N T, HUANG Z M, ZHANG Z Y, et al. Research progress of soybean isoflavones on anti-osteoporosis[J]. Chinese Journal of Experimental Surgery, 2018, 35(1): 176-178. doi: 10.3760/cma.j.issn.1001-9030.2018.01.057
[65]	李硕, 王建. 大豆异黄酮临床应用的研究进展[J]. 大豆科学,2020,39(4):633−640. [LI S, WANG J. Research progress on the clinical application of soybean isoflavones[J]. Soybean Science,2020,39(4):633−640. LI S, WANG J. Research progress on the clinical application of soybean isoflavones[J]. Soybean Science, 2020, 39(4): 633-640.
[66]	TAKU K, MELBY M K, NISHI N, et al . Soy isoflavones for osteoporosis: An evidence-based approach[J]. Maturitas, 2011, 70(4): 333−338.
[67]	罗伟, 王亚芹, 冯晗, 等. 杜仲抗骨质疏松及其机制研究进展[J]. 中国临床药理学与治疗学,2016,21(12):1434−1440. [LUO W, WANG Y Q, FENG H, et al. Research progress of Eucommia ulmoides anti-osteoporosis and its mechanism[J]. Chinese Journal of Clinical Pharmacology and Therapeutics,2016,21(12):1434−1440. LUO W, WANG Y Q, FENG H, et al. Research progress of Eucommia ulmoides anti-osteoporosis and its mechanism[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2016, 21(12): 1434-1440.
[68]	刘聪, 郭非非, 肖军平, 等. 杜仲不同部位化学成分及药理作用研究进展[J]. 中国中药杂志,2020,45(3):497−512. [LIU C, GUO F F, XIAO J P, et al. Progress in research on chemical constituents and pharmacological effects of different parts of Eucommia ulmoides[J]. China Journal of Chinese Materia Medica,2020,45(3):497−512. LIU C, GUO F F, XIAO J P, et al. Progress in research on chemical constituents and pharmacological effects of different parts of Eucommia ulmoides[J]. China Journal of Chinese Materia Medica, 2020, 45(3): 497-512.
[69]	袁真, 闵珺, 王恺, 等. 杜仲黄酮类3种药物成分治疗大鼠骨质疏松的比较研究[J]. 中国骨质疏松杂志,2018,24(2):244−248. [YUAN Z, MIN J, WANG K, et al. Effects of different pharmacological components of eucommia ulmoide s flavonoids on postmenopausal oste oporosis[J]. Chinese Journal of Osteoporosis,2018,24(2):244−248. doi: 10.3969/j.issn.1006-7108.2018.02.022 YUAN Z, MIN J, WANG K, et al. Effects of different pharmacological components of eucommia ulmoide s flavonoids on postmenopausal oste oporosis[J]. Chinese Journal of Osteoporosis, 2018, 24(2): 244-248. doi: 10.3969/j.issn.1006-7108.2018.02.022
[70]	陆思成. 青娥丸治疗绝经后肾阳虚型骨质疏松症的临床疗效观察[D]. 长沙: 湖南中医药大学, 2020. LU S C. Observation on the clinical efficacy of Qing'e Pill in treating postmenopausal osteoporosis with kidney-yang deficiency [D]. Changsha: Hunan University of Chinese Medicine, 2020.
[71]	TANG W K, XIAO L, GE G R, et al. Puerarin inhibits titanium particle-induced osteolysis and RANKL-induced osteoclastogenesis via suppression of the NF-kappa B signaling pathway[J]. Journal of Cellular and Molecular Medicine,2020,24(20):11972−11983. doi: 10.1111/jcmm.15821
[72]	XIAO L, WANG Z R, ZHONG M D, et al. Puerarin alleviates osteoporosis in the ovariectomy-induced mice by suppressing osteoclastogenesis via inhibition of TRAF6/ROS-dependent MAPK/NF-kappa B signaling pathways[J]. Aging-Us,2020,12(21):21706−21729. doi: 10.18632/aging.103976
[73]	LI B, LIU M Y, WANG Y, et al. Puerarin improves the bone micro-environment to inhibit OVX-induced osteoporosis via modulating SCFAs released by the gut microbiota and repairing intestinal mucosal integrity[J]. Biomedicine & Pharmacotherapy,2020:110923.
[74]	WANG D R, LI J, FENG W Y, et al. Ligustilide suppresses RANKL-induced osteoclastogenesis and bone resorption via inhibition of RANK expression[J]. Journal of Cellular Biochemistry,2019,120(11):18667−18677. doi: 10.1002/jcb.29153
[75]	MA Z J, BAI L H. The anti-inflammatory effect of Z-ligustilide in experimental ovariectomized osteopenic rats[J]. Inflammation,2012,35(6):1793−1797. doi: 10.1007/s10753-012-9499-5
[76]	何树苗, 陈元堃, 曾奥, 等. 藁本内酯药理作用及机制研究进展[J]. 广东药科大学学报,2021,37(2):152−156. [HE S M, CHEN Y K, ZENG A, et al. Research progress of ligustilide pharmacological action and mechanism[J]. Journal of Guangdong Pharmaceutical University,2021,37(2):152−156. HE S M, CHEN Y K, ZENG A, et al. Research progress of ligustilide pharmacological action and mechanism[J]. Journal of Guangdong Pharmaceutical University, 2021, 37(2): 152-156.
[77]	YANG D S, LIU T, JIANG G Y, et al. Senkyunolide H attenuates osteoclastogenesis and postmenopausal osteoporosis by regulating the NF-kappa B, JNK and ERK signaling pathways[J]. Biochemical and Biophysical Research Communications,2020,533(3):510−518. doi: 10.1016/j.bbrc.2020.09.054
[78]	徐文霞. 健脾益肾活血法治疗糖尿病性骨质疏松症患者的临床研究及对P1NP、β-CTX的影响[D]. 合肥: 安徽中医药大学, 2020. XU W X. Clinical observation on the treatment of diabetic osteoporosis by strengthening spleen tonifying kidney and activating blood circulation and its effect on P1NP, β-CTX[D]. Hefei: Anhui University of Chinese Medicine, 2020.
[79]	TU Y B, YANG Y, LI Y F, et al. Naturally occurring coumestans from plants, their biological activities and therapeutic effects on human diseases[J]. Pharmacological Research,2021,169:105615. doi: 10.1016/j.phrs.2021.105615
[80]	袁婷婷, 张乃丹, 何勇静, 等. 天然药物中植物雌激素样化学成分的研究进展[J]. 中国中药杂志,2014,39(23):4526−4531. [YUAN T T, ZHANG N D, HE Y J, et al. Research progress of phytoestrogens-like chemical constituents in natural medicines[J]. China Journal of Chinese Materia Medica,2014,39(23):4526−4531. YUAN T T, ZHANG N D, HE Y J, et al. Research progress of phytoestrogens-like chemical constituents in natural medicines[J]. China Journal of Chinese Materia Medica, 2014, 39(23): 4526-4531.
[81]	KONG L B, MA R, YANG X B, et al. Psoralidin suppresses osteoclastogenesis in BMMs and attenuates LPS-mediated osteolysis by inhibiting inflammatory cytokines[J]. International Immunopharmacology,2017,51:31−39. doi: 10.1016/j.intimp.2017.07.003
[82]	CHAI L J, ZHOU K, WANG S X, et al. Psoralen and bakuchiol ameliorate M-CSF plus RANKL-induced osteoclast differentiation and bone resorption via inhibition of AKT and AP-1 pathways in vitro[J]. Cellular Physiology and Biochemistry,2018,48(5):2123−2133. doi: 10.1159/000492554
[83]	REN Y L, SONG X M, TAN L, et al. A review of the pharmacological properties of psoralen[J]. Frontiers in Pharmacology,2020,11:571535. doi: 10.3389/fphar.2020.571535
[84]	ZHENG X D, YU Y, SHAO B Y, et al. Osthole improves therapy for osteoporosis through increasing autophagy of mesenchymal stem cells[J]. Experimental Animals,2019,68(4):453−463. doi: 10.1538/expanim.18-0178
[85]	张建平, 谢兴文, 李建国, 等. 蛇床子提取物蛇床子素防治原发性骨质疏松症的研究概况[J]. 中国骨质疏松杂志,2020,26(10):1546−1549. [ZHANG J P, XIE X W, LI J G, et al. Research overview of osthole extract from Cnidium monnieri in preventing and treating primary osteoporosis[J]. Chinese Journal of Osteoporosis,2020,26(10):1546−1549. doi: 10.3969/j.issn.1006-7108.2020.10.030 ZHANG J P, XIE X W, LI J G, et al. Research overview of osthole extract from Cnidium monnieri in preventing and treating primary osteoporosis[J]. Chinese Journal of Osteoporosis, 2020, 26(10): 1546-1549. doi: 10.3969/j.issn.1006-7108.2020.10.030
[86]	刘元, 王立恒, 伊璠. 蛇床子素应用于骨质疏松治疗的研究进展[J]. 中国中医药现代远程教育,2020,18(4):133−135. [LIU Y, WANG L H, YI F. Research progress of osthol in the treatment of osteoporosis[J]. Chinese Medicine Modern Distance Education of China,2020,18(4):133−135. doi: 10.3969/j.issn.1672-2779.2020.04.056 LIU Y, WANG L H, YI F. Research progress of osthol in the treatment of osteoporosis[J]. Chinese Medicine Modern Distance Education of China, 2020, 18(4): 133-135. doi: 10.3969/j.issn.1672-2779.2020.04.056
[87]	WANG L N, ZHENG S Y, HUANG G C, et al. Osthole-loaded N-octyl-O-sulfonyl chitosan micelles (NSC-OST) inhibits RANKL-induced osteoclastogenesis and prevents ovariectomy-induced bone loss in rats[J]. Journal of Cellular and Molecular Medicine,2020,24(7):4105−4117. doi: 10.1111/jcmm.15064
[88]	MA Y, WANG L N, ZHENG S Y, et al. Osthole inhibits osteoclasts formation and bone resorption by regulating NF-kappa B signaling and NFATc1 activations stimulated by RANKL[J]. Journal of Cellular Biochemistry,2019,120(9):16052−16061. doi: 10.1002/jcb.28886
[89]	ZHU B, ZHANG Q L, HUA J W, et al. The traditional uses, phytochemistry, and pharmacology of Atractylodes macrocephala Koidz.: A review[J]. Journal of Ethnopharmacology,2018,226:143−167. doi: 10.1016/j.jep.2018.08.023
[90]	CAO S S, DONG X L, HO M X, et al. Oleanolic acid exerts osteoprotective effects and modulates vitamin D metabolism[J]. Nutrients, 2018, 10(2): 247.
[91]	梁文仪, 陈文静, 杨光辉, 等. 丹参酚酸类成分研究进展[J]. 中国中药杂志,2016,41(5):806−812. [LIANG W Y, CHEN W J, YANG G H, et al. Research progress on salvianolic acids of Salvia miltiorrhiza[J]. China Journal of Chinese Materia Medica,2016,41(5):806−812. LIANG W Y, CHEN W J, YANG G H, et al. Research progress on salvianolic acids of Salvia miltiorrhiza[J]. China Journal of Chinese Materia Medica, 2016, 41(5): 806-812.
[92]	李淑惠, 梁燕龙, 杨亚军, 等. 丹参水溶性成分影响骨代谢的机制研究进展[J]. 中国药理学通报,2016,32(7):902−905. [LI S H, LIANG Y L, YANG Y J, et al. Research progress of regulatory effects of water soluble compounds isolated form Salvia miltiorrhiza on bone metabolism[J]. Chinese Pharmacological Bulletin,2016,32(7):902−905. doi: 10.3969/j.issn.1001-1978.2016.07.004 LI S H, LIANG Y L, YANG Y J, et al. Research progress of regulatory effects of water soluble compounds isolated form Salvia miltiorrhiza on bone metabolism[J]. Chinese Pharmacological Bulletin, 2016, 32(7): 902-905. doi: 10.3969/j.issn.1001-1978.2016.07.004
[93]	熊义博. 中药丹参治疗骨质疏松的作用及其机制[J]. 医学信息,2020,33(9):44−46,56. [XIONG Y B. Study on the treatment of osteoporosis with Salvia miltiorrhiza[J]. Journal of Medical Information,2020,33(9):44−46,56. doi: 10.3969/j.issn.1006-1959.2020.09.014 XIONG Y B. Study on the treatment of osteoporosis with Salvia miltiorrhiza[J]. Journal of Medical Information, 2020, 33(9): 44-46, 56. doi: 10.3969/j.issn.1006-1959.2020.09.014
[94]	XIAO H H, GAO Q G, ZHANG Y, et al. Vanillic acid exerts oestrogen-like activities in osteoblast-like UMR 106 cells through MAP kinase (MEK/ERK)-mediated ER signaling pathway[J]. Journal of Steroid Biochemistry and Molecular Biology,2014,144:382−391. doi: 10.1016/j.jsbmb.2014.08.002
[95]	WANG H D, SHI Y M, LI L, et al. Treatment with resveratrol attenuates sublesional bone loss in spinal cord-injured rats[J]. British Journal of Pharmacology,2013,170(4):796−806. doi: 10.1111/bph.12301
[96]	ELSEWEIDY M M, EL-SWEFY S E, SHAHEEN M A, et al. Effect of resveratrol and mesenchymal stem cell monotherapy and combined treatment in management of osteoporosis in ovariectomized rats: Role of SIRT1/FOXO3a and Wnt/β-catenin pathways[J]. Archives of Biochemistry and Biophysics,2021,703:108856. doi: 10.1016/j.abb.2021.108856
[97]	苑翼楠, 周威. “药食同源”类食品国内外研究现状及展望[J]. 现代食品,2021(14):118−121. [YUAN Y N, ZHOU W. Existing research and prospect of "homology of medicine and food" in China and abroad[J]. Modern Food,2021(14):118−121. YUAN Y N, ZHOU W. Existing research and prospect of "homology of medicine and food" in China and abroad[J]. Modern Food, 2021(14): 118-121.
[98]	陈梁, 李小锋, 夏淑英, 等. 一种杜仲提取物及其在治疗骨质疏松中的应用: 中国, 111686147A[P]. 2020-09-22. CHEN L, LI X F, XIA S Y, et al. An extract of Eucommia ulmoides and its application in the treatment of osteoporosis: China, 111686147A[P]. 2020-09-22.
[99]	万永军, 黄健刚, 廖厚知. 一种抗骨质疏松的中药组合物及其制备方法: 中国, 106361856A[P]. 2017-02-01. WAN Y J, HUANG J G, LIAO H Z. An anti-osteoporosis Chinese medicine composition and its preparation method: China, 106361856A[P]. 2017-02-01.
[100]	康兴东, 肖军平, 吴永忠, 等. 一种抗骨质疏松的杜仲缓释片及其制备方法: 中国, 104666393A[P]. 2015-06-03. KANG X D, XIAO J P, WU Y Z, et al. An anti-osteoporotic eucommia ulmoides sustained-release tablet and its preparation method: China, 104666393A[P]. 2015-06-03.
[101]	薛梅, 张良, 芮佳, 等. 一种抗骨质疏松的保健食品: 中国, 108272080A[P]. 2018-07-13. XUE M, ZHANG L, RUI J, et al. A health food for anti-osteoporosis: China, 108272080A[P]. 2018-07-13.
[102]	魏建华, 赵花, 曹立军, 等. 一种增加骨密度的压片糖果及其制备方法: 中国, 110973335A[P]. 2020-04-10. WEI J H, ZHAO H, CAO L J, et al. A tablet candy with increased bone density and its preparation method: China, 110973335A[P]. 2020-04-10.
[103]	邢秋苓. 一种抗骨质疏松症的组合物的制备方法: 中国, 103816274A[P]. 2014-05-28. XING Q L. Preparation method of an anti-osteoporosis composition: China, 103816274A[P]. 2014-05-28.
[104]	刘颖. 一种保健粉: 中国, 110302285A[P]. 2019-10-08. LIU Y. A kind of health powder: China, 110302285A[P]. 2019-10-08.
[105]	李娇娇. 一种小麦复合面粉及其制备方法: 中国, 108142784A[P]. 2018-06-12. LI J J. A kind of wheat compound flour and its preparation method: China, 108142784A[P]. 2018-06-12.
[106]	胡安然. 骨质疏松全营养配方食品: 中国, 104187632A[P]. 2014-12-10. HU A R. Osteoporosis complete nutritional formula food: China, 104187632A[P]. 2014-12-10.
[107]	魏敏杰, 李博, 宫世强. 一种增加骨密度的多功能食品组合物及其制备方法: 中国, 108402460A[P]. 2018-08-17. WEI M J, LI B, GONG S Q. A multifunctional food composition for increasing bone density and its preparation method: China, 108402460A[P]. 2018-08-17.
[108]	钮立卫, 李洪, 刘德贤, 等. 一种增加骨密度的保健食品: 中国, 109601880A[P]. 2019-04-12. NIU L W, LI H, LIU D X, et al. A health food to increase bone density: China, 109601880A[P]. 2019-04-12.
[109]	余龙江, 刘浩, 陈晶晶. 一种可改善肝功能并预防骨质疏松的天然组合物及其制备方法: 中国, 110237166A[P]. 2019-09-17. YU L J, LIU H, CHEN J J. A natural composition that can improve liver function and prevent osteoporosis and its preparation method: China, 110237166A[P]. 2019-09-17.
[110]	程刚. 一种增加骨密度的含枸杞多糖的组合物: 中国, 111248445A[P]. 2020-06-09. CHENG G. A composition containing Lycium barbarum polysaccharides to increase bone density: China, 111248445A[P]. 2020-06-09.
[111]	周玉权, 王晓彦, 梅连杰, 等. 一种增加骨密度的组合物及其应用: 中国, 110101839A[P]. 2019-08-09. ZHOU Y Q, WANG X Y, MEI L J, et al. A composition for increasing bone density and its application: China, 110101839A[P]. 2019-08-09.

Supplements (0)

Cited By

Cited by

Periodical cited type(6)

1.	匡昱林，欧梁，匡建军，戎宽，孙绍裘. 金刚丸联合骨化三醇治疗肾阳亏虚型老年骨质疏松症的临床研究. 湖南中医药大学学报. 2024(05): 822-827 .
2.	符凯润，李昕蓉，魏小成，何军刚，贾妙婷，李岩，燕羽婷，谢鑫明，李成义. 红芪黄酮类成分药理作用及机制研究进展. 中草药. 2024(11): 3906-3915 .
3.	陈丽华，单雅慧，管咏梅，董欢欢，姜佳恩，梁淼，马伊宁，张永，黄通盛. 药食同源物质改善胃肠道功能作用的研究进展. 食品工业科技. 2023(04): 480-487 . 本站查看
4.	钱永帅，余惠凡，张艳，刘丽，曹文洁，李飞. 蒙花苷药理作用研究进展. 中药药理与临床. 2023(10): 124-128 .
5.	程建明，薛峰，张云羽，嵇晶，刘陶世. 药食同源产品研发现状、技术关键与对策. 南京中医药大学学报. 2023(09): 814-826 .
6.	张云，薛柯，代俊俊，苏亚菲，李钦. 杜仲叶总黄酮对去卵巢大鼠肠道菌群的影响. 河南大学学报(医学版). 2022(05): 327-333 .